Management of COVID-19 ICU-survivors in primary care: – a narrative review.
Management of COVID-19 ICU-survivors in primary care: – a narrative review – BMC Family Practice
The post Management of COVID-19 ICU-survivors in primary care: – a narrative review. appeared first on Links Medicus.
RCT: Rivaroxaban does not have an impact on disease progression and symptoms resolution in high-risk adults with mild COVID-19.
Randomized study of rivaroxaban vs. placebo on disease progression and symptoms resolution in high-risk adults with mild COVID-19 – Clinical Infectious Diseases
The post RCT: Rivaroxaban does not have an impact on disease progression and symptoms resolution in high-risk adults with mild COVID-19. appeared first on Links Medicus.
Systematic Review: Can electronic cigarettes help people stop smoking, and do they have any unwanted effects when used for this purpose?
Summary: Can electronic cigarettes help people stop smoking, and do they have any unwanted effects when used for this purpose? – Cochrane Library Original Study: Electronic cigarettes for smoking cessation – Cochrane Library Commentary on Twitter Can #ecigarettes help you #quitsmoking? Latest Evidence is in! https://t.co/04UN47MoOm pic.twitter.com/pDugyzeEmh — CochraneTAG (@CochraneTAG) September 14, 2021
The post Systematic Review: Can electronic cigarettes help people stop smoking, and do they have any unwanted effects when used for this purpose? appeared first on Links Medicus.
COVID vaccine effects wane over time but still prevent death and severe illness.
COVID vaccine effects wane over time but still prevent death and severe illness – The Conversation Related: Perspective | What we actually know about waning immunity. Another study shows Pfizer mRNA vaccine immunity is reduced over time. [Press release – not published yet] Study shows vaccine protection wanes over time, but vaccines still offer good protection […]
The post COVID vaccine effects wane over time but still prevent death and severe illness. appeared first on Links Medicus.
An observational study in Israel suggests additional protection from a 3rd dose of the Pfizer vaccine in individuals 60 years of age or older.
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel – New England Journal of Medicine
The post An observational study in Israel suggests additional protection from a 3rd dose of the Pfizer vaccine in individuals 60 years of age or older. appeared first on Links Medicus.
Case series: Vaccine-induced thrombocytopenia with severe headache may precede cerebral venous sinus thrombosis by several days – patients with severe headache 5 to 20 days after adenovirus vector vaccination against Covid-19 should undergo immediate test
Vaccine-Induced Thrombocytopenia with Severe Headache – New England Journal of Medicine Commentary on Twitter Experience with 11 patients suggests that elements of VITT (severe headache, elevated d-dimer levels, and positivity for anti-PF4 antibodies) after ChAdOx1 nCoV-19 vaccination may precede VITT. #Covid19Vaccines #COVID19 #SARSCoV2 #IDTwitter https://t.co/mzBgjJIE6l pic.twitter.com/wGqb1gKFXk — NEJM (@NEJM) September 15, 2021
The post Case series: Vaccine-induced thrombocytopenia with severe headache may precede cerebral venous sinus thrombosis by several days – patients with severe headache 5 to 20 days after adenovirus vector vaccination against Covid-19 should undergo immediate testing for thrombocytopenia and d-dimer levels and, if available, testing for anti–PF4–heparin IgG antibodies. appeared first on Links Medicus.
RCT: Remdesivir does not improve outcomes in patients admitted to hospital with COVID-19.
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial – The Lancet Infectious Diseases Invited commentary: Remdesivir, on the road to DisCoVeRy – The Lancet Infectious Diseases Related: Systematic Review: “Remdesivir probably has little or no […]
The post RCT: Remdesivir does not improve outcomes in patients admitted to hospital with COVID-19. appeared first on Links Medicus.
Management of high-risk pulmonary embolism in pregnancy.
Management of high-risk pulmonary embolism in pregnancy – Thrombosis Research
The post Management of high-risk pulmonary embolism in pregnancy. appeared first on Links Medicus.
Ivermectin: Cochrane’s most talked about review so far, ever. Why?
Ivermectin: Cochrane’s most talked about review so far, ever. Why? – Cochrane Library Original review: Systematic review: no evidence to support the use of Ivermectin for treating or preventing COVID-19. Commentary on Twitter Ivermectin: Cochrane’s most talked about review so far, ever. Why?https://t.co/KmOLR9qHrF#ivermectin #evidencesynthesis #systematicreviews #COVID19 #Cochrane #publichealth #globalhealth #medicine pic.twitter.com/twLyqzSrcF — Cochrane US […]
The post Ivermectin: Cochrane’s most talked about review so far, ever. Why? appeared first on Links Medicus.
CDC report finds unvaccinated people are 11 times more likely to die of COVID-19.
Unvaccinated People Are 11 Times More Likely To Die Of COVID-19, New Research Finds – NPR Original study: Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021 – CDC Morbidity and Mortality Weekly Report Commentary on Twitter New @CDCMMWR shows fully vaccinated people had […]
The post CDC report finds unvaccinated people are 11 times more likely to die of COVID-19. appeared first on Links Medicus.